LU0133096635
T. Rowe Price Funds SICAV - US Smaller Companies Equity Fund

  • Equities
  • US
  • USD Cash
  • Accumulating
Invest with
USD Cash
Payout type
Accumulating
Risk rating
6
About this fund
Description
To increase the value of its shares, over the long term, through growth in the value of its investments.
Key information
Annual report
Product Highlight Sheet
Prospectus
Information Memorandum
Factsheet
Our perspective
Why we think this fund is best-in-class
product
Product
Long standing US Small and mid cap strategy (launched in 2001) that is style neutral with broad exposure to both growth and value small and mid-cap companies.
Read more
people
People
Portfolio Managers Curt Organt and Matt Mahon collectively have more than 40 years of experience. They are supported by the broader equity research team of more than 50 analysts. Receive significant support from the broader team of T.Rowe Price portfolio managers and analysts, who advise and suggest candidates for the portfolios.Large analyst pool is crucial for small cap investing as it is an inefficient space and understanding both the opportunities and the risks associated with smaller companies is key to identifying the winnersT. Rowe Price, as a firm, is one of the pioneers in small cap investing with more than 70bn USD in AUM in small cap funds. T. rowe has been managing US small cap strategies since 1960.
Read more
performance
Performance
The strategy was launched in 2001 and has outperformed its benchmark since inception with stock selection driving the outperformance. Downside capture has been very strong, losing less than the market and this has allowed the strategy to generate strong returns across all market cycles; lower downside capture has helped the fund to compound its returns over the long term.
Read more
process
Process
Bottom up process with a focus on free cash flow metrics, as the team believes FCF to be the purest measure of corporate financial performance and is central to determining value in the small and mid-cap market.Ideal candidates are companies below 18bn in market capitalisation with durable competitive advantages and a strong management team capable of adding value through the cycle. Resulting portfolio is between 150 to 200 holdings with broad exposure to both growth and value stocks that are within the market capitalization range of the Russell 2500 Index at time of purchase.
Read more
cost
Cost
Endowus offers retail share class with 100% trailer fee rebated back to Endowus investors to achieve lower cost of access.
Read more
selectionCriteria
How it fits in a portfolio
Investors looking for exposure to smaller US companies can consider the Fund as a satellite exposure to complement their core equity holding. While the Fund is diversified with 150-200 holdings and a small average holding size , it focuses on smaller companies that are typically more volatile in nature. Therefore, investors should be mindful of the risk involved, although the Fund’s performance has shown that investors have historically been rewarded for taking such risks. This Fund is also country specific and investors should ensure that they construct their portfolio to build more diversity and avoid concentration risks.Updated as of 2024/07/23
Read more
Invest in this fund
Performance
Shows the total return of this accumulating fund, which includes dividends reinvested.
Total returns
All Time
419.71%
YTD
1.97%
1 month
2.45%
6 month
4.66%
1 year
2.78%
3 year
26.61%
5 year
45.79%
10 year
171.05%
As of Aug 2025
Distributions
This is an accumulating fund, so dividends are re-invested at the fund level.
Risk metrics
Max drawdown
-50.03%As of Aug 2025
Volatility
18.02%As of Aug 2025
Calendar returns
YearTotalJanFebMarAprMayJunJulAugSepOctNovDec
2025-2.8%-5.2%-6.0%-4.4%6.8%4.7%1.7%2.4%----
20246.3%-0.9%2.8%3.3%-5.3%1.7%-0.8%5.6%-0.7%1.4%-0.7%8.4%-7.7%
202322.5%7.8%0.4%-3.6%-0.2%-0.5%7.5%3.7%-1.9%-4.4%-6.4%10.0%9.8%
2022-21.1%-10.6%1.2%2.9%-6.1%-3.9%-8.7%10.4%-2.1%-8.6%7.0%0.7%-3.1%
202115.9%2.4%4.0%1.2%5.0%-2.0%0.8%0.8%1.5%-1.6%4.2%-3.4%2.4%
Top Exposures
PTC Inc2.47%
APi Group Corp2.20%
Elanco Animal Health Inc1.95%
Haemonetics Corp1.88%
Teledyne Technologies Inc1.75%
Regions Financial Corp1.58%
Parsons Corp1.57%
Revvity Inc1.54%
Atmos Energy Corp1.48%
OGE Energy Corp1.37%
Frontdoor Inc1.29%
Vontier Corp Ordinary Shares1.26%
Silgan Holdings Inc1.24%
Ingersoll Rand Inc1.22%
CubeSmart1.15%
Top exposures represent up to 15 of the fund's largest exposures for each category. Allocation percentages may not sum up to 100% and can include negative values due to rounding or trading activities by the underlying fund managers, including short positions.
Fund fees
1.69%0.81% p.a.
Save 52%
Save up to 65% in fees
Invested elsewhere? Transfer your funds to Endowus in four easy steps. Learn more
fee comparison
Fund facts
ISIN
LU0133096635
Fund house
T. Rowe Price
Fund size
US$3.3B
As of 10 Sep 2025
Fund benchmark
Morningstar US Small Extended NR USD
Fund inception date
31 Jul 2001
Fund class currency
USD
Fund share class
A USD
Oldest share class ISIN
LU0133096635
Oldest share inception date
31 Jul 2001
Pricing frequency
Daily

Disclaimer: ©2025 Morningstar. All Rights Reserved. The information contained here relating to a particular collective investment scheme: (1) is proprietary to Morningstar Research Pte. Limited and/or its content providers (“Information Provider(s)“) unless otherwise specified; and (2) may not be copied or distributed. Neither the Information Provider nor Endowus guarantee or endorse the accuracy, reliability, completeness or timeliness of the information, or are responsible for any damages or losses arising from any use of this information. Further, for technical reasons, certain information provided by Information Provider may be different from that supplied by the respective fund houses.

This website is for information purposes only and is not and should not be construed as an offer or the solicitation of an offer or a recommendation for the purchase or sale of any investment or subscribe for, or to participate in, any services. Any opinion or estimate above is made on a general basis and none of Endowus, nor any of its affiliates, representatives, or agents have given any consideration to nor have made any investigation of the objective, financial situation, or particular need of any user, reader, any specific person or group of persons. Opinions expressed herein are subject to change without notice. You should carefully consider whether any investment views and investment products/services are appropriate in view of your investment experience, objectives, financial resources and relevant circumstances or seek financial advice via Endowus' platform.

Investment involves risk. The value of investments and the income from them can go down as well as up, and you may not get the full amount you invested. Past performance is not an indicator nor a guarantee of future performance. Rates of exchange may cause the value of investments to go up or down. Individual stock performance does not represent the return of a fund.

You are responsible for downloads from this website. Endowus does not warrant that any downloads from this website will meet your needs or expectations, or be uninterrupted, secure, or error free or that any files available for downloading through this website are free of computer viruses or other harmful components. You alone are responsible for ensuring adequate protection and backup of data, software, computer, and other equipment is made and appropriate safeguard is in place to detect, prevent and eliminate computer viruses and other harmful effects. Neither Endowus nor the Information Provider will be responsible for any costs or expenses which may be incurred if your use of this website or if any downloads results in any servicing or replacement of property, material, equipment, or data.

This advertisement has not been reviewed by the Monetary Authority of Singapore.